Research into acute leukemia moves towards "tailor-made" treatments for each individual patient Published on 22/11/2022 Research into acute leukemia is currently one of the most active fields in Spain due to the shortcomings persisting in the treatment of these patients, who amount to more than 6,000 every year1
Theragnostics and a multidisciplinary approach, keys to the treatment of neuroendocrine tumors Published on 10/11/2022 These are rare tumors, around 3,000 to 4,000 cases a year in this country, and they can appear in anywhere in the body
Spanish scientists identify a new treatment strategy against a very aggressive subtype of breast cancer Published on 19/10/2022 HER2+ breast cancer, diagnosed in 7,000 new cases in 2022, is a very aggressive subtype of poor prognosis because most patients develop drug resistance
MD Anderson Cancer Center Madrid – Hospiten is positioned as one of the hundred best cancer centers in the world Published on 07/10/2022 The hospital is ranked number 71 in the ranking, according to the "World's Best Specialized Hospitals 2023" report, prepared by Newsweek magazine and Statista
Better pain management or possible demedicalized approaches open up new treatment paths in palliative care in oncology Published on 07/10/2022 More than 90,000 cancer patients require palliative care each year in Spain according to the Spanish Cancer Association (AECC)
Vacunación y continuidad en el uso de la mascarilla, las recomendaciones de los expertos a los pacientes oncológicos frente a la gripe Published on 27/09/2022 Las enfermedades infecciosas respiratorias son un riesgo añadido para los pacientes oncológicos por su inmunosupresión
La investigación de biomarcadores en cáncer de vejiga optimiza la selección de pacientes candidatos a inmunoterapia Published on 23/09/2022 Un estudio, donde participa MD Anderson Cancer Center Madrid – Hospiten, muestra que la selección más certera de los pacientes que responderán a la inmunoterapia podría reducir los niveles de toxicidad, al evitar la administración de fármacos con reducidas probabilidades de éxito
The combination of targeted therapies and immunotherapy are the future for patients with advanced thyroid cancer Published on 19/09/2022 The new approach for the advanced stages of the disease incorporates immunotherapy to treatment, with the aim of maintaining the benefits of targeted therapies for the patient over time
MRIs of fewer than 7 minutes to improve the diagnosis and monitoring of breast cancer Published on 29/08/2022 The protocol encourages greater adherence to the technique and due to the reduced duration of the procedure, MRIs can be used on a greater number of patients
Prolonged abdominal pain with no apparent cause and unexplained weight loss may be a warning of a gastrointestinal tumor Published on 02/08/2022 The symptoms of gastrointestinal tumors vary greatly and depend on the type of tumor and where it is located, so they must be studied individually. Although colorectal cancer is the most common, the incidence of other gastrointestinal tumors, like pancreatic or stomach tumors, has increased in recent years. Risk factors for gastrointestinal tumors include a poor diet, physical inactivity, alcohol consumption and smoking